Inventor · disambiguated record
Harald Stauss
Also filed as: STAUSS HARALD
7 granted patents·5 pending applications·89 citations·filing 1997–2004
84Inventor score
Top patents by PatentIndex Score
12 records- 0193US6737405B2Stabilized protein preparation and process for its preparationAVENTIS BEHRING GMBH·Filed 2001·Granted May 18, 2004·55 cites·11 claims
- 0266US6399572B1Pharmaceutical preparation for the treatment of inflammatory processesAVENTIS BEHRING GMBH·Filed 2000·Granted Jun 4, 2002·4 cites·6 claims
- 0359US2004162412A1Stabilized protein preparation and process for its preparationAVENTIS BEHRING GMBH·Filed 2004·Application pending·0 cites
- 0457US6395881B1Separation of antithrombin III α and β variants by cyclodextrin-modified micellar electrokinetic chromatographyAVENTIS BEHRING GMBH·Filed 2001·Granted May 28, 2002·3 cites·34 claims
- 0552US6906183B2Process for the separation of glycosylated and nonglycosylated proteinsDELTA BIOTECHNOLOGY LTD·Filed 1999·Granted Jun 14, 2005·8 cites·11 claims
- 0650US6117647AProcess for quantifying glycosaminoglycans in antithrombin III-containing solutionsAVENTIS BEHRING GMBH·Filed 1997·Granted Sep 12, 2000·15 cites·5 claims
- 0747US6790832B2Pharmaceutical preparation for the treatment of inflammatory processesAVENTIS BEHRING GMBH·Filed 2002·Granted Sep 14, 2004·0 cites·6 claims
- 0842US2004229795A1Use of antithrombin III for the prophylaxis and therapy of diseasesAVENTIS BEHRING GMBH·Filed 2004·Application pending·0 cites
- 0942US2004161810A1Monoclonal antibodies specific for latent antithrombin III and the use thereofFiled 2003·Application pending·0 cites
- 1041US2003134796A1Antithrombin for the prevention and therapy of vasculoproliferative disordersFiled 2002·Application pending·0 cites
- 1137US6514940B2Stabilized antithrombin III preparationAVENTIS BEHRING GMBH·Filed 1999·Granted Feb 4, 2003·4 cites·12 claims
- 1231US2002119143A1Antithrombin III for disorders caused by angiogenesisFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →